Loading company
ISRGIntuitive Surgical, Inc.$155.8BA+Built from Angiodynamics Inc.’s own filings with the U.S. Securities and Exchange Commission (SEC). Figures are as reported, with per-share history restated onto today’s share basis. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.
The themes Angiodynamics is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
ANGO · Nasdaq · Healthcare · Medical Instruments and Supplies
$12.42+2.9%Nov 11 close
Figures through August 31, 2026, from the 10-Q filed October 8, 2026
Company outlook: revenue of $336M to $341M for Fiscal year 2027 — up 5.7% on a year earlier
Grade C-
The band under the price shows the grade on each date, built only from filings that were public by then.
Showing 2 of 40 quarters of Angiodynamics Inc.’s grade history. The other 38 go back to January 2017.
